文献速递生殖医学

高同型半胱氨酸血症与代谢综合征对多囊卵巢综合征女性生殖的影响:一项二次分析

Effects of hyperhomocysteinaemia and metabolic syndrome on reproduction in women with polycystic ovary syndrome: a secondary analysis.
PubMed 文献 · Reprod Biomed Online · 2019-01-18

该研究为PCOSAct的二次分析,纳入中国21个中心1000例多囊卵巢综合征(PCOS)女性,其中936例有基线同型半胱氨酸(HCY)数据。高HCY与较高的体重指数、游离睾酮和较低的FSH、空腹血糖相关,且与排卵率降低相关;高同型半胱氨酸血症(HHCY)组排卵率降低、孕中晚期流产率升高;代谢综合征组排卵、受孕、妊娠、孕中晚期流产和活产率均较低。结论认为HHCY导致流产增加和排卵减少,代谢综合征与多个生殖阶段缺陷相关。

要点

  • 高HCY与排卵率降低相关(OR 0.59,95%CI 0.41-0.86;OR 0.57,95%CI 0.39-0.83)。
  • HHCY组排卵率降低、孕中晚期流产率升高(OR 1.678,95%CI 1.04-2.70;OR 0.03,95%CI 0.00-0.42)。
  • 代谢综合征组排卵、受孕、妊娠、孕中晚期流产和活产率均较低。

核心结论

  • 在PCOS女性中,HHCY导致流产增加和排卵减少,代谢综合征与排卵、受孕、妊娠、流产和活产缺陷相关,表明两种状况在不同生殖阶段导致缺陷。

研究设计与样本

  • PCOSAct的二次分析,中国21个中心,纳入1000例PCOS女性,其中936例有基线HCY数据被分析。

主要发现

  • 较高的HCY与较高的体重指数、游离睾酮和较低的FSH、空腹血糖相关(P < 0.001;P < 0.001;P = 0.005;P < 0.001)。
  • 在所有参与者中,HCY第二和第三三分位组与第一三分位组相比,排卵率的OR分别为0.59(95%CI 0.41-0.86)和0.57(95%CI 0.39-0.83)。
  • HHCY组雌二醇较低、游离睾酮较高(P = 0.04;P < 0.001)。
  • 代谢综合征组LH、LH-FSH比值和性激素结合球蛋白最低(所有P < 0.001)。
  • HHCY组与对照组相比,排卵率降低、孕中晚期流产率升高(OR 1.678,95%CI 1.04-2.70;OR 0.03,95%CI 0.00-0.42),经治疗调整。

关键数值与推荐

  • HHCY组与对照组相比,排卵率降低(OR 1.678,95%CI 1.04-2.70),孕中晚期流产率升高(OR 0.03,95%CI 0.00-0.42),经治疗调整。
  • 代谢综合征组与对照组相比,经治疗调整后排卵、受孕、妊娠、孕中晚期流产和活产率的OR分别为1.76(95%CI 1.15-2.70)、1.75(95%CI 1.15-2.65)、2.09(95%CI 1.27-3.44)、0.02(95%CI 0.00-0.33)、2.42(95%CI 1.42-4.10)。
  • 进一步调整治疗和性激素因素后,代谢综合征组与对照组的妊娠、流产和活产率仍有显著差异(OR 1.77,95%CI 1.05-2.99;OR 0.14,95%CI 0.02-0.82;OR 2.02,95%CI 1.16-3.50)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the association between hyperhomocysteinaemia (HHCY), metabolic syndrome, and reproductive outcomes among women with polycystic ovary syndrome (PCOS). DESIGN: A secondary analysis of PCOSAct with 21 sites in China. A total of 1000 women with PCOS were enrolled; 936 women with baseline homocysteine (HCY) were analysed. RESULTS: Higher HCY was associated with higher body mass index, free testosterone and lower FSH, fasting glucose (P < 0.001; P < 0.001; P = 0.005; P < 0.001) and ovulation rate among all participants (OR 0.59, 95% CI 0.41 to 0.86; OR 0.57, 95% CI 0.39 to 0.83 tertiles 2 and 3 versus tertile 1, respectively). The HHCY group had lower oestradiol and higher free testosterone (P = 0.04; P < 0.001) than the controls. In the metabolic syndrome group, LH, LH-FSH ratio and sex hormone-binding globulin were lowest in the metabolic syndrome group (all P < 0.001). In the HHCY group, ovulation rate decreased and the second or third trimester pregnancy loss rate increased compared with controls (OR 1.678, 95% CI 1.04 to 2.70; OR 0.03, 95% CI 0.00 to 0.42) with treatment adjustment. Compared with the controls, ovulation, conception, pregnancy, second or third trimester pregnancy loss and live birth rates were statistically lower in the metabolic syndrome group after adjusting treatment (OR 1.76, 95% CI 1.15 to 2.70; OR 1.75, 95% CI 1.15 to 2.65; OR 2.09, 95% CI 1.27 to 3.44; OR 0.02, 95% CI 0.00 to 0.33; OR 2.42 95% CI 1.42 to 4.10), and pregnancy, pregnancy loss and live birth rates remained significantly different after adjusting for treatment and sex-hormone factors (OR 1.77, 95% CI 1.05 to 2.99; OR 0.14, 95% CI 0.02 to 0.82; OR 2.02, 95% CI 1.16 to 3.50). CONCLUSIONS: In women with PCOS, HHCY contributes to increased pregnancy loss and reduced ovulation, and metabolic syndrome was related to defects in ovulation, conception, pregnancy, pregnancy loss and live birth, indicating that the two conditions lead to defects at various reproductive stages.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Chang H, Xie L, Ge H, et al. Effects of hyperhomocysteinaemia and metabolic syndrome on reproduction in women with polycystic ovary syndrome: a secondary analysis. Reprod Biomed Online. 2019. PMID: 30979610. doi:10.1016/j.rbmo.2018.12.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。